Muscle Spasticity
Conditions
Brief summary
This study will examine the epidemiology (incidence and control of a disease), burden, clinical need, and treatment patterns of spasticity in patients with a diagnosis of Cerebral Palsy (CP), Multiple Sclerosis (MS), Stroke, Spinal Cord Injury (SCI), or Traumatic Brain Injury (TBI).
Interventions
There is no intervention administered in this study.
Sponsors
Study design
Eligibility
Inclusion criteria
-Diagnosis of Cerebral Palsy (CP), Multiple Sclerosis (MS), Stroke, Spinal Cord Injury (SCI), or Traumatic Brain Injury (TBI) for a minimum of 3 months
Exclusion criteria
-Participation in a spasticity clinical trial in the past 5 years.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Investigator Assessment of Spasticity Severity using a 5-Point Scale | Day 1 |
| Percentage of Participants with Spasticity not Receiving Treatment | Day 1 |
| Spasticity Symptom Assessment Score using a 21-item Questionnaire | Day 1 |
| Spasticity Impact Assessment Score using a 32-item Questionnaire | Day 1 |
Secondary
| Measure | Time frame |
|---|---|
| Referral Patterns for Spasticity Management | Day 1 |
| Spasticity Screening Tool Score using a 13-item Questionnaire | Day 1 |
| Percentage of Participants with Spasticity Receiving Treatment | Day 1 |
Countries
United States